GeneDx Corp. (WGS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

GeneDx Corp.

NASDAQ: WGS · Real-Time Price · USD
118.26
0.89 (0.76%)
At close: Oct 03, 2025, 3:59 PM
118.35
0.08%
After-hours: Oct 03, 2025, 07:15 PM EDT

GeneDx Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-52.29M -175.77M -548.98M -245.39M
Depreciation & Amortization
21.95M 35.83M 59.31M 21.81M
Stock-Based Compensation
9.14M -326K 41.98M 219.42M
Other Working Capital
3.72M -2.53M -8.46M 13.17M
Other Non-Cash Items
17.79M -721K 141.53M 1.62M
Deferred Income Tax
-343K -926K -49.12M -195.97M
Change in Working Capital
-24.75M -38.24M 36.13M 8.08M
Operating Cash Flow
-28.5M -180.15M -319.15M -190.43M
Capital Expenditures
-5.49M -5.71M -14.32M -20.79M
Cash Acquisitions
n/a -8.11M -127M n/a
Purchase of Investments
-66.3M -47.67M n/a n/a
Sales Maturities Of Investments
41.66M 17.77M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-30.13M -43.73M -141.33M -20.79M
Debt Repayment
-3.23M 42.95M -3.29M -13.47M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
891K 285K 2.95M 64.51M
Financial Cash Flow
44.16M 186.24M 197.31M 493.73M
Net Cash Flow
-14.47M -37.72M -263.17M 282.51M
Free Cash Flow
-33.99M -185.86M -333.48M -211.22M